Delivery Order SPE2DB22D2206-SPE2DB24FEU60
- Not listed
- This contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of TALZENNA 0.25 MG CAPSULE 30S to the Defense Logistics Agency (DLA) Troop Support Medical. The firm fixed price delivery order, valued at $10,040.85, has a completion date of February 12, 2024. Amerisourcebergen Drug Corp, as the prime contractor, will deliver the pharmaceutical product to the DLA Troop Support Medical facility located in Conshohocken, Pennsylvania. This award...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of TALZENNA 0.5 MG CAPSULE 30S, a pharmaceutical product. The contract has a ceiling value of $21,568.70 and a period of performance through March 7, 2025. It is a firm fixed-price contract and does not have any set-aside designation. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,784.34 firm fixed-price delivery order is for the supply of TALZENNA 0.5 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of February 26, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of TALZENNA 0.5 MG CAPSULE 30S, a prescription medication. The delivery order has a ceiling value of $10,424.08 and a completion date of October 21, 2024. This contract is not set aside for any small business or socioeconomic category. Amerisourcebergen has been awarded numerous federal contracts by the DLA...
- This federal contract award, valued at $10,784.34, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a delivery order for the medical product TALZENNA 0.5 MG CAPSULE 30S, with a performance period ending on March 27, 2025. The contract is a firm fixed-price arrangement, and there is no set-aside designation indicated. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a...
- This federal contract award, valued at $10,424.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of TALZENNA 1 MG CAPSULE 30S pharmaceutical product. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary...
- This federal contract award, valued at $10,784.34, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The award covers the delivery of 4566702246 TALZENNA 0.5 MG CAPSULE 30S, a pharmaceutical product, with a completion date of January 6, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies. The company...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company. The contract, valued at $30,008.88, is for the supply of a specialty medication, Talzenna 1 mg capsule, with a completion date of March 4, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation. This award is issued under a larger indefinite delivery contract (IDC) between...
- This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TALZENNA 0.35 MG SOFTGEL 30S, with a ceiling value of $11,135.25 and a period of performance through July 29, 2025. The contract is not set aside and was competitively awarded. Amerisourcebergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,135.25 firm-fixed-price contract is for the delivery of TALZENNA 0.35 MG SOFTGEL 30S, a pharmaceutical product. The contract has an ultimate completion date of June 3, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FEU60Delivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of TALZENNA 1 MG CAPSULE 30S, a pharmaceutical product, with a potential value of $20,005.92. The order has a completion date of January 18, 2024. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contract awards from DLA to provide pharmaceutical products and medical supplies in support of military treatment programs and facilities. The company's corporate office is located in Conshohocken, Pennsylvania, which serves as the place of performance for this contract. No set-aside designation was used for this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.0k | 12/26/23 |